| Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability A Randomized Control Trial LJ Craven, A Rahman, SN Parvathy, M Beaton, J Silverman, K Qumosani, ... The American Journal of Gastroenterology, 2020 | 219 | 2020 |
| Extended screening costs associated with selecting donors for fecal microbiota transplantation for treatment of metabolic syndrome-associated diseases LJ Craven, S Nair Parvathy, J Tat-Ko, JP Burton, MS Silverman Open forum infectious diseases 4 (4), ofx243, 2017 | 52 | 2017 |
| Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial KF Al, LJ Craven, S Gibbons, SN Parvathy, AC Wing, C Graf, KA Parham, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (2 …, 2022 | 40 | 2022 |
| Nutritional, microbial, and allergenic changes during the fermentation of cashew ‘cheese’product using a quinoa-based rejuvelac starter culture JM Chen, KF Al, LJ Craven, S Seney, M Coons, H McCormick, G Reid, ... Nutrients 12 (3), 648, 2020 | 25 | 2020 |
| Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going? RM Chanyi, L Craven, B Harvey, G Reid, MJ Silverman, JP Burton SAGE Open Medicine 5, 2050312117708712, 2017 | 16 | 2017 |
| Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening … LJ Craven, M Silverman, JP Burton Annals of Translational Medicine 5 (24), 2017 | 9 | 2017 |
| Intestinal microbiota transfer—updating the nomenclature to increase acceptability LJ Craven, JR McIlroy, BH Mullish, JR Marchesi Alimentary Pharmacology & Therapeutics 52 (10), 1622-1623, 2020 | 6 | 2020 |
| Nutritional, microbial, and allergenic changes during the fermentation of cashew ‘cheese’product using a quinoa-based rejuvelac starter culture. Nutrients. 2020. 12: 648 JM Chen, KF Al, LJ Craven, S Seney, M Coons, H McCormick, G Reid, ... | 5 | 2020 |
| Optimizing Fecal Microbiota Transplantations For Therapeutic Use Beyond Clostridioides difficile Infection LJ Craven Western University, 2020 | 1 | 2020 |
| Response to Ianiro et al. LJ Craven, SN Parvathy, JP Burton, MS Silverman Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | | 2021 |
| Reply to Ianiro et al. LJ Craven, SN Parvathy, JP Burton, MS Silverman Official journal of the American College of Gastroenterology| ACG, 2021 | | 2021 |
| Fecal microbial transplantation in multiple sclerosis: trial design A Wing, SM Kerfoot, K Parham, JP Burton, LJ Craven, J Meddings, ... MULTIPLE SCLEROSIS JOURNAL 24, 327-327, 2018 | | 2018 |
Jeremy P. BurtonLawson Health Research Institute, Schulich, Surgery, Microbiology & Immunology, uwoПодтвержден адрес электронной почты в домене uwo.ca
